https://glpletter.com 2026-10-20T19:41:50.371Z daily 1 https://glpletter.com/sections/drug-delivery-beyond-injections 2026-10-14T17:41:53.387Z weekly 0.5 https://glpletter.com/sections/nanoparticle-and-peptide-therapeutics 2026-10-18T19:36:02.316Z weekly 0.5 https://glpletter.com/sections/glp-1-side-effects-and-patient-experience 2026-10-07T19:10:46.199Z weekly 0.5 https://glpletter.com/sections/emerging-glp-1-indications 2026-10-06T17:35:41.085Z weekly 0.5 https://glpletter.com/sections/features 2026-10-20T19:41:50.371Z weekly 0.5 https://glpletter.com/sections/nose-to-brain-n2b-delivery 2026-09-26T05:50:23.013Z weekly 0.5 https://glpletter.com/sections/glp-1-science-and-mechanisms 2026-10-09T18:45:31.984Z weekly 0.5 https://glpletter.com/authors/amara-osei-bonsu 2026-10-20T19:41:50.371Z weekly 0.4 https://glpletter.com/authors/tobias-wrenfield 2026-10-20T19:41:50.371Z weekly 0.4 https://glpletter.com/authors/mei-lin-tso 2026-10-20T19:41:50.371Z weekly 0.4 https://glpletter.com/authors/priya-subramaniam 2026-10-20T19:41:50.371Z weekly 0.4 https://glpletter.com/posts/glp-1-patches-don-t-exist-yet-here-s-what-the-side-effect-data-would-look-like https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/e227f041-2b40-44eb-972b-1faeea25c354.jpeg 2026-10-20T19:41:50.371Z monthly 0.7 https://glpletter.com/posts/how-the-lungs-absorb-peptides-and-where-that-breaks-down-for-glp-1s https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/df992ba5-5c19-4a93-9f40-3f526938ef13.jpeg 2026-10-19T19:21:30.114Z monthly 0.7 https://glpletter.com/posts/columbia-university-nanoparticle-spinout-ip-versus-big-pharma-formulation-patent https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/dd67be10-984a-4161-91c6-43495d1471a3.jpeg 2026-10-18T19:36:02.316Z monthly 0.7 https://glpletter.com/posts/scoring-the-nose-to-brain-peptide-field-by-platform-depth-ip-age-and-cns-indicat https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/82bbd067-175b-44ad-95d1-58e7c0632127.jpeg 2026-10-16T17:56:43.855Z monthly 0.7 https://glpletter.com/posts/glp-1-receptor-agonists-as-neurological-pipeline-candidates-enabled-by-nose-to-b https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/0a5dfba8-c33f-4073-a8c0-f6a92dc805e9.jpeg 2026-10-15T17:56:38.811Z monthly 0.7 https://glpletter.com/posts/intranasal-glp-1-delivery-as-the-clinical-bridge-for-needle-averse-patients-who https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/2edbb6d9-6a5e-49b0-a9a1-2b2766944d1c.jpeg 2026-10-14T17:41:53.387Z monthly 0.7 https://glpletter.com/posts/why-glp-1-patches-have-not-made-it-to-market https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/30081909-41e2-4deb-bdf8-8bf05389b068.jpeg 2026-10-13T19:11:43.457Z monthly 0.7 https://glpletter.com/posts/what-inhaled-insulin-taught-us-about-delivering-peptides-through-the-lung https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/795b4024-9124-4713-80a6-b47eabdef390.jpeg 2026-10-12T19:26:17.887Z monthly 0.7 https://glpletter.com/posts/intellectual-property-strategy-for-nanoparticle-drug-delivery-platforms https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/db9d7e99-ee2a-410a-8a54-41208b75fa84.jpeg 2026-10-11T18:26:15.834Z monthly 0.7 https://glpletter.com/posts/does-tirzepatide-suppress-appetite-or-burn-fat-directly https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/c6713b2d-1ebe-448d-8426-acc41dbf7a2c.jpeg 2026-10-09T18:45:31.984Z monthly 0.7 https://glpletter.com/posts/glp-1-receptor-agonist-drug-class-overview https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/990bca25-1bd0-4cf8-8dd7-88638e803316.jpeg 2026-10-08T19:35:36.431Z monthly 0.7 https://glpletter.com/posts/muscle-and-lean-mass-loss-during-glp-1-therapy https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/9388f867-f262-4d2a-8507-c56095ae45f9.jpeg 2026-10-07T19:10:46.199Z monthly 0.7 https://glpletter.com/posts/glp-1-receptor-agonists-and-dementia-risk-reduction-research https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/9f40be63-1ad4-4ff3-ac47-22b6f1ae12ee.png 2026-10-06T17:35:41.085Z monthly 0.7 https://glpletter.com/posts/liraglutide-vs-semaglutide-structural-and-pharmacological-differences https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/59c44e19-ed2f-44f2-8d93-72da9240bbff.jpeg 2026-10-04T18:55:16.503Z monthly 0.7 https://glpletter.com/posts/mucosal-absorption-barriers-for-peptide-biologics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/33105b15-f1cc-42e9-adf0-a22c612dfb42.jpeg 2026-10-03T19:44:46.094Z monthly 0.7 https://glpletter.com/posts/peptide-stability-engineering-for-non-injectable-formulations https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/5fd695d8-de8f-4a8d-acf4-710ef248054b.jpeg 2026-10-02T19:40:55.508Z monthly 0.7 https://glpletter.com/posts/companies-developing-intranasal-routes-for-glp-1-and-metabolic-peptide-delivery https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/2a0ddd7d-0743-49b1-97d7-ef9c2eacd1f9.jpeg 2026-10-01T18:36:38.238Z monthly 0.7 https://glpletter.com/posts/nanoparticle-platforms-engineered-for-direct-nose-to-brain-peptide-transport https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/b61756d1-0230-404c-a41f-78fdce9974f7.jpeg 2026-09-30T19:20:56.945Z monthly 0.7 https://glpletter.com/posts/nanoparticle-drug-delivery-systems-in-approved-therapies https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/43410980-aa9b-45e8-9289-264eedf539f0.jpeg 2026-09-30T17:16:53.632Z monthly 0.7 https://glpletter.com/posts/drugs-that-can-cross-the-blood-brain-barrier https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/cfe4eac2-ab4a-449d-8ae2-d77304142fef.jpeg 2026-09-30T16:21:37.454Z monthly 0.7 https://glpletter.com/posts/drug-delivery-nanoparticle-platform-types-compared https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/96711de0-c7f1-4985-a83c-8fabc9baa2bd.jpeg 2026-09-29T06:50:22.936Z monthly 0.7 https://glpletter.com/posts/approved-intranasal-cns-drugs-and-their-delivery-mechanisms https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/0e13392a-0f09-4a8f-8e48-42d184a196f9.jpeg 2026-09-26T05:50:23.013Z monthly 0.7 https://glpletter.com/posts/nasal-epithelium-barriers-to-cns-drug-delivery https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/70f7f0d9-7f47-4719-a142-8142caf31084.jpeg 2026-09-25T00:39:22.694Z monthly 0.7 https://glpletter.com/posts/nose-to-brain-delivery-in-neurodegenerative-disease-research https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/ef1640ce-3d07-45ad-a5c9-403722477fa2.jpeg 2026-09-22T18:30:14.012Z monthly 0.7 https://glpletter.com/posts/nose-to-brain-delivery-for-large-molecule-biologics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/8d26b583-3576-400b-a859-89423902f4c2.jpeg 2026-09-20T18:49:21.936Z monthly 0.7 https://glpletter.com/posts/glp-1-side-effect-profile-and-treatment-discontinuation-rates https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/d11f6113-a0de-4cca-9cdf-400e52207ab1.jpeg 2026-09-19T19:19:15.959Z monthly 0.7 https://glpletter.com/posts/gastroparesis-risk-with-glp-1-agonist-use https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/f69fa05d-8a3a-4e8b-877b-cc0b1a3ebb1a.jpeg 2026-09-18T19:50:22.786Z monthly 0.7 https://glpletter.com/posts/glp-1-skin-and-hypersensitivity-reactions https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/21aefb6b-e168-42c8-a1a9-926876c05a0c.jpeg 2026-09-16T18:45:41.485Z monthly 0.7 https://glpletter.com/posts/glp-1-side-effects-after-stopping-treatment https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/cfec1511-68a9-43fe-8298-fa92f368591b.png 2026-09-15T23:33:53.970Z monthly 0.7 https://glpletter.com/posts/glp-1-gastrointestinal-mechanisms-behind-nausea-and-diarrhea https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/3bdc891d-b739-4f5e-949f-df82768ce51d.jpeg 2026-09-15T22:29:07.383Z monthly 0.7 https://glpletter.com/posts/glp-1-injection-site-reactions-and-subcutaneous-tissue-effects https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/a8ff8f11-65dc-4606-8a60-0f83f6f40e96.jpeg 2026-09-13T03:36:24.482Z monthly 0.7 https://glpletter.com/posts/duration-and-resolution-of-glp-1-nausea-and-vomiting https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/12ffa5f2-b1ed-4291-bec5-2e29f6952785.jpeg 2026-09-12T03:42:26.433Z monthly 0.7 https://glpletter.com/posts/glp-1-long-term-side-effects-in-chronic-users https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/7bd62b3f-9cb4-488f-8d8e-90552e674a95.jpeg 2026-09-11T03:27:48.434Z monthly 0.7 https://glpletter.com/posts/patient-adherence-measurement-methods-in-chronic-peptide-therapy https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/d9390c51-ab58-45d7-a907-133b657504ca.jpeg 2026-09-10T01:07:47.897Z monthly 0.7 https://glpletter.com/posts/sublingual-and-buccal-peptide-delivery-feasibility https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/897181b8-e4ee-46a9-952d-fabf55e0ec34.jpeg 2026-09-08T22:29:03.073Z monthly 0.7 https://glpletter.com/posts/long-acting-injectable-formulations-and-implantable-depots https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/da440118-85d0-4e36-b629-b643673bcf29.jpeg 2026-09-08T05:25:23.982Z monthly 0.7 https://glpletter.com/posts/transdermal-peptide-delivery-research-and-current-limits https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/3b6157f5-29cc-46fb-8019-ae40fd0a007b.jpeg 2026-09-05T21:48:15.886Z monthly 0.7 https://glpletter.com/posts/transdermal-peptide-delivery-technologies-in-development https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/6c5bc15f-c697-44f0-bbcd-df4075f7be05.jpeg 2026-09-04T18:45:15.569Z monthly 0.7 https://glpletter.com/posts/needle-aversion-and-injection-anxiety-in-chronic-disease-management https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/834b3ecf-33fe-4392-b5a1-7ddb84f4255a.jpeg 2026-09-03T18:44:42.887Z monthly 0.7 https://glpletter.com/posts/peptide-bioavailability-benchmarks-across-delivery-routes https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/996ab5d3-9bcf-43a0-8907-c10d222cf2ac.jpeg 2026-09-01T21:14:05.306Z monthly 0.7 https://glpletter.com/posts/injection-fatigue-and-device-innovation-in-biologic-delivery https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/72ccf6d4-915e-44c1-ac93-3e57fd05d54c.jpeg 2026-08-30T17:47:10.568Z monthly 0.7 https://glpletter.com/posts/subcutaneous-vs-alternative-delivery-routes-for-glp-1-therapeutics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/949dd588-b520-433a-af43-fb846989eeca.jpeg 2026-08-29T18:27:13.499Z monthly 0.7 https://glpletter.com/posts/oral-semaglutide-bioavailability-and-absorption-limitations https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/341f0100-ff63-4f6f-a604-ff14c35d6793.png 2026-08-28T19:31:21.893Z monthly 0.7 https://glpletter.com/posts/glp-1-and-cardiovascular-risk-reduction-mechanisms https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/27fce4c4-3c16-4196-aa5c-db7248a74134.png 2026-08-27T17:36:39.147Z monthly 0.7 https://glpletter.com/posts/glp-1-agonists-in-non-alcoholic-fatty-liver-disease https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/9a832be3-b049-4489-ba2f-ee8b1dd98814.png 2026-08-26T21:52:26.944Z monthly 0.7 https://glpletter.com/posts/glp-1-effects-on-sleep-architecture-and-metabolic-recovery https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/8877f478-6f6a-4f23-971e-d25bd3400996.png 2026-08-25T19:32:45.448Z monthly 0.7 https://glpletter.com/posts/glp-1-receptors-in-nicotine-and-opioid-craving-reduction https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/19ed20ea-3dab-451d-be97-4903e61522a8.png 2026-08-25T17:18:39.162Z monthly 0.7 https://glpletter.com/posts/glp-1-agonists-and-parkinson-s-disease-neuroprotection https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/35167b36-0b1a-429f-b1cd-5a6e503b8687.png 2026-08-24T05:16:44.607Z monthly 0.7 https://glpletter.com/posts/glp-1-receptor-activation-and-opioid-craving-reduction https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/a6dc339d-8224-4986-9881-8463ebce9a12.png 2026-08-22T18:43:38.858Z monthly 0.7 https://glpletter.com/posts/obesity-brain-axis-and-hypothalamic-inflammation https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/4faff090-54b1-4796-a49b-8f0e7d965881.png 2026-08-21T17:48:44.693Z monthly 0.7